Yu, Yun Fei, Aihua Wu, Zengbin Gao, Chengjin and Pan, Shuming 2017. Intravenous polymyxins: Revival with puzzle. BioScience Trends, Vol. 11, Issue. 4, p. 370.
Lee, Chang-Ro Lee, Jung Hun Park, Moonhee Park, Kwang Seung Bae, Il Kwon Kim, Young Bae Cha, Chang-Jun Jeong, Byeong Chul and Lee, Sang Hee 2017. Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Frontiers in Cellular and Infection Microbiology, Vol. 7,
Lee, Chun-Yuan Huang, Chung-Hao Lu, Po-Liang Ko, Wen-Chien Chen, Yen-Hsu and Hsueh, Po-Ren 2017. Role of rifampin for the treatment of bacterial infections other than mycobacteriosis. Journal of Infection, Vol. 75, Issue. 5, p. 395.
Kengkla, Kirati Kongpakwattana, Khachen Saokaew, Surasak Apisarnthanarak, Anucha and Chaiyakunapruk, Nathorn 2017. Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis. Journal of Antimicrobial Chemotherapy,
Srinivas, Pavithra and Rivard, Kaitlyn 2017. Polymyxin Resistance in Gram-negative Pathogens. Current Infectious Disease Reports, Vol. 19, Issue. 11,
Zusman, Oren Altunin, Sergey Koppel, Fidi Dishon Benattar, Yael Gedik, Habip and Paul, Mical 2017. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy, Vol. 72, Issue. 1, p. 29.
Tiwari, Vishvanath Tiwari, Monalisa and Solanki, Vandana 2017. Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell. Frontiers in Immunology, Vol. 8,
Shin, Bora and Park, Woojun 2017. Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy. Journal of Microbiology, Vol. 55, Issue. 11, p. 837.
Wenzler, Eric Goff, Debra A. Humphries, Romney and Goldstein, Ellie J. C. 2017. Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections. Infectious Diseases and Therapy, Vol. 6, Issue. 2, p. 149.
Zayyad, Hiba Eliakim-Raz, Noa Leibovici, Leonard and Paul, Mical 2017. Revival of old antibiotics: needs, the state of evidence and expectations. International Journal of Antimicrobial Agents, Vol. 49, Issue. 5, p. 536.
Aguado, J.M. Silva, J.T. Fernández-Ruiz, M. Cordero, E. Fortún, J. Gudiol, C. Martínez-Martínez, L. Vidal, E. Almenar, L. Almirante, B. Cantón, R. Carratalá, J. Caston, J.J. Cercenado, E. Cervera, C. Cisneros, J.M. Crespo-Leiro, M.G. Cuervas-Mons, V. Elizalde-Fernández, J. Fariñas, M.C. Gavaldà, J. Goyanes, M.J. Gutiérrez-Gutiérrez, B. Hernández, D. Len, O. López-Andujar, R. López-Medrano, F. Martín-Dávila, P. Montejo, M. Moreno, A. Oliver, A. Pascual, A. Pérez-Nadales, E. Román-Broto, A. San-Juan, R. Serón, D. Solé-Jover, A. Valerio, M. Muñoz, P. and Torre-Cisneros, J. 2017. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplantation Reviews,
Idelevich, Evgeny A. Lanckohr, Christian Horn, Dagmar Wieler, Lothar H. Becker, Karsten and Köck, Robin 2016. Antibiotika-resistente Erreger in Deutschland. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Vol. 59, Issue. 1, p. 113.
Garnacho-Montero, José Gutiérrez-Pizarraya, Antonio Díaz-Martín, Ana Cisneros-Herreros, José Miguel Cano, María Eugenia Gato, Eva Ruiz de Alegría, Carlos Fernández-Cuenca, Felipe Vila, Jordi Martínez-Martínez, Luis Tomás-Carmona, M. del Mar Pascual, Álvaro Bou, Germán Pachón-Diaz, Jerónimo and Rodríguez-Baño, Jesús 2016. Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality. Enfermedades Infecciosas y Microbiología Clínica, Vol. 34, Issue. 9, p. 551.
Kalil, Andre C. Metersky, Mark L. Klompas, Michael Muscedere, John Sweeney, Daniel A. Palmer, Lucy B. Napolitano, Lena M. O'Grady, Naomi P. Bartlett, John G. Carratalà, Jordi El Solh, Ali A. Ewig, Santiago Fey, Paul D. File, Thomas M. Restrepo, Marcos I. Roberts, Jason A. Waterer, Grant W. Cruse, Peggy Knight, Shandra L. and Brozek, Jan L. 2016. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases, Vol. 63, Issue. 5, p. e61.
Clark, Nina M. Zhanel, George G. and Lynch, Joseph P. 2016. Emergence of antimicrobial resistance among Acinetobacter species. Current Opinion in Critical Care, Vol. 22, Issue. 5, p. 491.
Parchem, N. L. Bauer, K. A. Cook, C. H. Mangino, J. E. Jones, C. D. Porter, K. and Murphy, C. V. 2016. Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia. European Journal of Clinical Microbiology & Infectious Diseases, Vol. 35, Issue. 9, p. 1433.
Özvatan, Tülay Akalın, Halis Sınırtaş, Melda Ocakoğlu, Gökhan Yılmaz, Emel Heper, Yasemin Kelebek, Nermin İşçimen, Remzi and Kahveci, Ferda 2016. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases. Respirology, Vol. 21, Issue. 2, p. 363.
The aim of this study was to compare the responses of colistin treatment alone vs. a combination of colistin and rifampicin in the treatment of ventilator-associated pneumonia (VAP) caused by a carbapenem-resistant A. baumannii strain. Forty-three patients were randomly assigned to one of two treatment groups. Although clinical (P = 0·654), laboratory (P = 0·645), radiological (P = 0·290) and microbiological (P = 0·597) response rates were better in the combination group, these differences were not significant. However, time to microbiological clearance (3·1 ± 0·5 days, P = 0·029) was significantly shorter in the combination group. The VAP-related mortality rates were 63·6% (14/22) and 38·1% (8/21) for the colistin and the combination groups (P = 0·171), respectively. Our results suggest that the combination of colistin with rifampicin may improve clinical and microbiological outcomes of VAP patients infected with A. baumannii.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 24th November 2017. This data will be updated every 24 hours.